These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 36860920)
1. Impact of tissue inhibitor of metalloproteinases-3 genetic variants on clinicopathological characteristics of urothelial cell carcinoma. Weng WC; Hsieh MH; Chiou HL; Lee CY; Tang CH; Chang LC; Wang SS; Yang SF J Cancer; 2023; 14(3):360-366. PubMed ID: 36860920 [TBL] [Abstract][Full Text] [Related]
2. Associations of Chang JH; Lai TC; Yang PJ; Shih PC; Yang YC; Lee KL; Liu TC; Tsao TC; Yang SF; Chien MH Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126605 [TBL] [Abstract][Full Text] [Related]
3. Effect of tissue inhibitor of metalloproteinases-3 genetics polymorphism on clinicopathological characteristics of uterine cervical cancer patients in Taiwan. Chung JF; Chen CL; Nassef Y; Shiu BH; Wang CH; Kuo FH; Hsiao YH; Yang SF; Wang PH Int J Med Sci; 2022; 19(6):1013-1022. PubMed ID: 35813301 [TBL] [Abstract][Full Text] [Related]
4. Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma. Tsay MD; Hsieh MJ; Lee CY; Wang SS; Chen CS; Hung SC; Lin CY; Yang SF Int J Environ Res Public Health; 2019 Dec; 17(1):. PubMed ID: 31878098 [TBL] [Abstract][Full Text] [Related]
5. Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics. Li CC; Hsieh MJ; Wang SS; Hung SC; Lin CY; Kuo CW; Yang SF; Chou YE Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31940762 [TBL] [Abstract][Full Text] [Related]
6. Impact of Clinicopathological Characteristics and Tissue Inhibitor of Metalloproteinase-3 Polymorphism Rs9619311 on Biochemical Recurrence in Taiwanese Patients with Prostate Cancer. Hsieh CY; Lin CY; Wang SS; Chou YE; Chien MH; Wen YC; Hsieh MJ; Yang SF Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612628 [TBL] [Abstract][Full Text] [Related]
7. Associations of VEGF-C genetic polymorphisms with urothelial cell carcinoma susceptibility differ between smokers and non-smokers in Taiwan. Tung MC; Hsieh MJ; Wang SS; Yang SF; Chen SS; Wang SW; Lee LM; Lee WJ; Chien MH PLoS One; 2014; 9(3):e91147. PubMed ID: 24608123 [TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population. Tung MC; Wen YC; Wang SS; Lin YW; Liu YC; Yang SF; Chien MH Int J Med Sci; 2018; 15(11):1187-1193. PubMed ID: 30123056 [TBL] [Abstract][Full Text] [Related]
9. TIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women. Tsai HT; Hsieh MJ; Chiou HL; Lee HL; Hsin MC; Liou YS; Yang CC; Yang SF; Kuo WH Tumour Biol; 2014 Sep; 35(9):8999-9007. PubMed ID: 24903383 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral Cancer. Su CW; Huang YW; Chen MK; Su SC; Yang SF; Lin CW Medicine (Baltimore); 2015 Nov; 94(46):e2092. PubMed ID: 26579821 [TBL] [Abstract][Full Text] [Related]
11. Impact of Long Non-Coding RNA Tung MC; Wen YC; Wang SS; Lin YW; Chow JM; Yang SF; Chien MH J Clin Med; 2019 Feb; 8(3):. PubMed ID: 30813594 [TBL] [Abstract][Full Text] [Related]
12. WISP1 genetic variants as predictors of tumor development with urothelial cell carcinoma. Lee HL; Chiou HL; Wang SS; Hung SC; Chou MC; Yang SF; Hsieh MJ; Chou YE Urol Oncol; 2018 Apr; 36(4):160.e15-160.e21. PubMed ID: 29277583 [TBL] [Abstract][Full Text] [Related]
13. Impact of RAGE polymorphisms on urothelial cell carcinoma clinicopathologic characteristics and long-term survival. Hung SC; Wang SS; Li JR; Chen CS; Lin CY; Chang LW; Chiu KY; Cheng CL; Ou YC; Yang SF Urol Oncol; 2019 Sep; 37(9):573.e9-573.e17. PubMed ID: 30824390 [TBL] [Abstract][Full Text] [Related]
14. An analysis of the polymorphisms of the GLUT1 gene in urothelial cell carcinomas of the bladder and its correlation with p53, Ki67 and GLUT1 expressions. Xu C; Yang X; Wang Y; Ding N; Han R; Sun Y; Wang Y Cancer Gene Ther; 2017 Jul; 24(7):297-303. PubMed ID: 28524154 [TBL] [Abstract][Full Text] [Related]
15. Effects of Long Noncoding RNA H19 Polymorphisms on Urothelial Cell Carcinoma Development. Yang PJ; Hsieh MJ; Hung TW; Wang SS; Chen SC; Lee MC; Yang SF; Chou YE Int J Environ Res Public Health; 2019 Apr; 16(8):. PubMed ID: 31013794 [TBL] [Abstract][Full Text] [Related]
16. Impact of Gene Polymorphisms in GAS5 on Urothelial Cell Carcinoma Development and Clinical Characteristics. Weng WC; Chen CJ; Chen PN; Wang SS; Hsieh MJ; Yang SF Diagnostics (Basel); 2020 Apr; 10(5):. PubMed ID: 32354045 [TBL] [Abstract][Full Text] [Related]
17. Effect of Hung SC; Wang SS; Li JR; Chen CS; Yang CK; Chiu KY; Cheng CL; Ou YC; Ho HC; Yang SF Int J Med Sci; 2018; 15(14):1731-1736. PubMed ID: 30588197 [TBL] [Abstract][Full Text] [Related]
18. Impact of endothelial nitric oxide synthase polymorphisms on urothelial cell carcinoma development. Tsay MD; Hsieh MJ; Wang SS; Wang WC; Chou YY; Shih CH; Yang SF; Chou YE Urol Oncol; 2019 Apr; 37(4):293.e1-293.e9. PubMed ID: 30611644 [TBL] [Abstract][Full Text] [Related]
19. Prostate specific membrane antigen (PSMA) in urothelial cell carcinoma (UCC) is associated with tumor grading and staging. Schreiber H; Hänze J; Nimphius W; Verburg FA; Luster M; Hofmann R; Hegele A J Cancer Res Clin Oncol; 2020 Feb; 146(2):305-313. PubMed ID: 31897687 [TBL] [Abstract][Full Text] [Related]
20. Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma. Brait M; Munari E; LeBron C; Noordhuis MG; Begum S; Michailidi C; Gonzalez-Roibon N; Maldonado L; Sen T; Guerrero-Preston R; Cope L; Parrella P; Fazio VM; Ha PK; Netto GJ; Sidransky D; Hoque MO Cell Cycle; 2013 Apr; 12(7):1058-70. PubMed ID: 23435205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]